###begin article-title 0
P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
###end article-title 0
###begin p 1
Conflict of interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
Objective: Mutated p53 gene is related to the instability of cell growth and cell cycle progression. We aimed to evaluate the association between endometriosis and p53 codon 11, 72 and 248 gene polymorphisms.
###end p 2
###begin p 3
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq </italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BstU</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hap </italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 22 27 <span type="species:ncbi:9606">Women</span>
Patients and methods: Women were divided into two groups: (1) moderate/severe endometriosis (n=148), and (2) non-endometriosis groups (n=150). P53 gene polymorphisms include codon11 Glu/Gln or Lys (GAG->CAG or AAG), codon 72 Arg/Pro (CGC->CCC), and codon 248 Arg/Thr (CGG->TCG). These gene polymorphisms were amplified by polymerase chain reaction and detected by electrophoresis after restriction enzyme (Taq I, BstU I, Hap II) digestions. Associations between the endometriosis and p53 polymorphisms were evaluated.
###end p 3
###begin p 4
Results: The distributions of p53 codon 72 polymorphisms in both groups were significantly different. The proportions of Arg homozygotes/heterozygotes/Pro homozygotes in both groups were 9.5/66.2/24.3% and 30.7/50/19.3%. The proportions of Arg/Pro alleles were 42.6/57.4% and 56/44%. The distributions of p53 codon 11 and 248 polymorphisms in both groups were non-significantly different. All individuals appeared the wild genotypes (Glu11 and Arg248 homozygotes).
###end p 4
###begin p 5
Conclusion: Association between endometriosis and p53 codon 72 polymorphism exists. P53 codon 72*Pro-related genotype and allele are related with higher susceptibility of endometriosis. P53 codon 11 and 248 polymorphisms are not related with endometriosis susceptibility.
###end p 5
###begin title 6
1. Introduction
###end title 6
###begin p 7
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Endometriosis, a common polygenic/multifactorial disease, might be caused by an interaction between multiple genes as well as the environment 1. Endometriosis displays features similar to malignancy, including local invasion and aggressive spread to distant organs. Its monoclonal origin indicates the neoplastic and genetic natures of most endometriotic lesions 2. Genomic alterations may represent important events in the development of endometriosis. Tumor suppressor genes play a role in the regulation of cell growth and prevention of carcinogenesis. The altered tumor suppressor genes might be related with the development of endometriosis 3.
###end p 7
###begin p 8
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
p53, a representative tumor suppressor, is involved in cell proliferation and progression of various tumor types. There is discrepancy about this presentation of p53 polymorphisms and various tumors. The p53*Arg72 homozygote is considered to be a risk factor in the development of cancer 4. In contrast, some investigators demonstrated the non-association between the different p53 polymorphisms and individual cancer development 5; other studies revealed the higher risks in the individuals with p53*Pro72 homozygote 6,7. Furthermore, some investigators also demonstrated the associations of individual disorders with p53 codon 248 (Table 5).
###end p 8
###begin p 9
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 530 535 <span type="species:ncbi:9606">women</span>
Scanty literature presented the association between the endometriosis and p53 polymorphism. High frequency of p53 locus deletion was observed in the endometriosis specimens 8. The p53 protein abnormalities and chromosomal aberrations may be involved in malignant transformation of ovarian endometriosis 9. In contrast, some investigators have demonstrated the undetectable expression of p53 in the endometriosis specimens 10-12. To resolve these issues, we aimed to detect the p53 codon 11, 72, and 248 polymorphisms in Taiwanese women with or without endometriosis. To the best of our knowledge, this report is the largest survey in this aspect. Furthermore, it is also the first report about the distributions of p53 codon 11 and 248 polymorphisms in endometriosis.
###end p 9
###begin title 10
2. Material and methods
###end title 10
###begin p 11
###xml 25 30 <span type="species:ncbi:9606">women</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 473 478 <span type="species:ncbi:9606">women</span>
###xml 789 794 <span type="species:ncbi:9606">women</span>
Pre-menopausal Taiwanese women with surgically and histologically diagnosed endometriosis were included prospectively. All patients were divided into two groups: (1) moderate/severe endometriosis (n=119, according to revised American Fertility Society classification); and (2) non-endometriosis group (n=108). The non-endometriosis statuses were confirmed during the cesarean section or diagnostic laparoscopy. All operations were performed by same surgeon (Hsieh YY). All women accepted the peripheral blood sampling for genotype analyses. There were non-significant differences between both groups in age, weight, and height. The experiment was approved by Ethical Committee and Institutional Review Board of the China Medical University Hospital. Informed consent was signed by all the women who donated their blood.
###end p 11
###begin p 12
The genomic DNA was prepared from peripheral blood leukocytes by use of a genomic DNA isolation kit (Blossom, Taipei, Taiwan). A total of 50 ng genomic DNA was mixed with 20 pmol of each polymerase chain reaction (PCR) primer in a total volume of 25 mul containing 10 mM Tris-HCL pH 8.3, 50 mM potassium chloride, 2.0 mM magnesium chloride, 0.2 mM each deoxyribonucleotide triphosphate, and 1 U DNA polymerase (Amplitag; Perkin-Elmer, Foster City, CA, USA).
###end p 12
###begin p 13
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
The primer Pro72 was designed for p53 codon 72 in proline (Pro) form and Arg72 for arginine (Arg) form, according to the procedure described by Storey et al. 4. P53codon 11 and 248 gene polymorphisms were determined according as the modified conditions of previous reports 13. The SNP information for the genes involved was obtained through internet (). The PCR conditions and restriction digestion of each SNP were listed in Table 1. The PCR amplification was performed in a programmable thermal cycler GenAmp PCR system 2400 (Perkin Elmer Applied Biosystems, Foster City, CA, USA). After PCR amplification, the individual gene polymorphisms were analyzed by gel electrophoresis of the PCR products after restriction enzyme digestions (New England Biolabs, Inc, Beverly, MA). The primer sequences, PCR conditions and related base pairs for the wild and mutant types were listed in Table 1.
###end p 13
###begin p 14
###xml 354 355 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 402 403 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Genotypes and allelic frequencies for p53 codon 11, 72 and 248 gene polymorphisms in both groups were compared. Correlations of these gene polymorphisms and endometriosis were evaluated. Allelic frequencies are expressed as a percentage of the total number of alleles. The SAS package (Version 8.1, SAS Institute Inc., Cary, North Carolina, USA) with chi2 test was utilized for statistical analyses. A p-value of <.05 was considered statistically significant.
###end p 14
###begin title 15
3. Results
###end title 15
###begin p 16
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Genotype proportions of different p53 codon 11 gene polymorphisms in both groups were non-significantly different (Table 2). All individuals appeared the wild genotype (Glu11) and allele. Proportions of p53*Glu homozygote/heterozygote (Glu/Gln, Glu/Lys)/Gln or Lys homozygote in both groups were: (1) 100/0/0% and (2) 100/0/0%, respectively. The proportions of Glu/Gln/Lys alleles in both groups were all 100/0/0%. There was no mutated genotype (p53 codon 11*Glu/Glu, Glu/Lys, Glu/Gln, Lys/Lys) observed in all individuals.
###end p 16
###begin p 17
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
In contrast, the proportions of different p53 codon 72 genotypes in both groups were significantly different. The proportions of Arg homozygote/heterozygote/Pro homozygote in endometriosis and non-endometriosis populations were 9.5/66.2/24.3% and 30.7/50/19.3%, respectively (p-value=0.0001, Table 3). The distributions of Arg/Pro alleles in both groups were 42.6/57.4% and 56/44%, respectively (p-value=0.001, Table 3). There were increased numbers of Pro-related genotype (Pro homozygote and Arg/Pro heterozygote) and allele in endometriosis group compared to non-endometriosis group. It suggested the correlations between the Pro72 and endometriosis.
###end p 17
###begin p 18
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
Genotype proportions of p53 codon 248 polymorphisms in both groups were also non-significantly different (Table 4). Proportions of p53 codon 248*Arg homozygote/heterozygote (Arg/Trp, Arg/Gln)/Trp or Gln homozygotes in both groups were: (1) 100/0/0% and (2) 100/0/0%, respectively. The proportions of Arg/Trp/Gln alleles in both groups were all 100/0/0% (Table 4). All individuals in both groups appear the wild (Arg248) genotype and allele. There was no mutated genotype (Trp, Gln) for p53 codon 248 observed in all individuals.
###end p 18
###begin title 19
4. Discussion
###end title 19
###begin p 20
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 38 43 <span type="species:ncbi:9606">women</span>
###xml 182 187 <span type="species:ncbi:9606">women</span>
Endometriosis is a common disorder in women, but its etiology remains unclear. The prevalence of endometriosis is 10% in the general population 14 and as high as 30-40% in infertile women 15. Some heritable genetic defects might contribute to the development of endometriosis 16. Somatic genetic alterations have been identified in endometriotic lesions, which might be related to its initiation and progression 17. Kosugi et al.18 demonstrated the increased heterogeneity and aneuploidy of chromosome 17 in endometriosis specimen. Because p53 is located in chromosome 17, the chromosome 17 aneuploidy might impair the function of p53, which influences the further progression of endometriosis.
###end p 20
###begin p 21
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 124 134 <span type="species:ncbi:111938">gatekeeper</span>
The p53 gene and its encoded protein are related with the regulation of cell cycle, cellular growth, and apoptosis. It is a gatekeeper or guardian of the cell division 19. The p53 mutations are associated with instability of cell development and cycle progression 20. The wild-type p53 protein is a DNA-binding transcription factor that activates other tumor suppressor genes (e.g., p21, MDM2, GADD45, Bax), that are required for the regulation of cell cycle progression or apoptosis in response to DNA damage 21. Alterations of p53 are related to the induction of apoptosis in malignant tumors.
###end p 21
###begin p 22
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
Individuals lacking functional p53 might be associated with tumor development. Abnormal p53 presentation has been observed in some tumor specimens, including the cervical carcinoma 22, ovarian carcinoma 23, bladder cancer 24, prostate cancer 25, hepatoma 7, gastric cancer 26, lung cancer 7, brain tumor 27, esophageal carcinoma 28, breast cancer 29, lymphoma 30, etc. Mutated p53 gene or malfunctioned p53 protein has often observed in patients with most types of malignancies 20.
###end p 22
###begin p 23
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
Single nucleotide polymorphisms (SNPs) provide a new way for the identification of complex gene-associated diseases such as endometriosis. Tumor suppressor-related SNPs might directly or indirectly affect tumor progression as well as the further interruption of cell cycles. Allelic polymorphisms that occur in the regulatory regions of these tumor suppressor genes are closely associated with malignant changes. Reviewing MEDLINE database, we observed the correlation of numerous p53 gene polymorphisms with individual diseases (Table 5). However, few investigators demonstrated their correlation with endometriosis.
###end p 23
###begin p 24
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 543 551 <span type="species:ncbi:9606">patients</span>
In fact, there are discrepancies about the distribution of p53 polymorphism in different malignancy. The p53 Arg72 homozygote is a significant risk factor in the development of invasive form of human papilloma virus-associated cancers 4. In contrast, some investigators demonstrated the non-association between the cervical cancer and different p53 polymorphisms 5. Furthermore, some reports even revealed that Pro72 homozygote is a risk factor of lung and hepatocellular carcinoma 7. In the study of lung carcinoma, Wang et al.35 found those patients with p53 Arg72 or Pro72 homozygous had worse prognoses compared with those with the heterozygous form.
###end p 24
###begin p 25
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 831 837 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Recently, Omori et al.31 demonstrated that the non-association between the endometriosis and p53 codon 72 polymorphism. In their study, the proportions of Arg homozygotes/heterozygotes/Pro homozygotes in endometriosis and control groups were 35.2/48.6%/16.2% and 39.4/41.7/18.9 %, respectively. We can see their controls' distributions were compatible with ours. However, the percentage in endometriosis individuals is different from that of ours. This discrepancy may be due to the different endometriosis staging or racial variation. In this series, we observed that Arg72 homozygote is related with lower susceptibility of endometriosis development. The Pro forms of codon 72 in p53 (Pro homozygotes or heterozygotes) are related with the higher susceptibility of endometriosis development. Our finding was compatible with Wang et al.7 and Yu et al.6, who demonstrated the association between the Pro homozygotes and lung or hepatocellular carcinoma. Combined these above studies, it suggested the dominant p53* Pro forms is associated with the development of endometriosis in Taiwanese population.
###end p 25
###begin p 26
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
Most cancer-related mutations of p53 are clustered in the four so-called 'hot spots', codon 175, 248, 273 and 281/282 32. Numerous reports presented the correlation statuses of p53 codon 248 polymorphism and individual diseases (Table 5). In this study, we noted the mutated somatic mutation of p53 condon 11 and 248 could not be observed in the peripheral lymphocytes from endometriosis populations. Therefore, these two SNPs will not become useful candidates for the suspecting the susceptibility of endometriosis. Presumably, the distinct biological condition caused by p53 genotype will be among various genetic, dietary, and environmental factors regulating hormonal and non-hormonal conditions in the development of endometriosis. These differences also reflect the etiological contributions of endogenous rather than exogenous factors to endometriosis. Furthermore, these polymorphisms might be in linkage disequilibrium with an unidentified functional polymorphism in p53 that influences endometriosis susceptibility.
###end p 26
###begin p 27
In conclusion, the association between endometriosis and p53 polymorphism exists. The p53 Arg72 homozygotes are related with lower susceptibility of endometriosis development. The Pro72 homozygotes or heterozygotes are related with higher susceptibility of endometriosis development. The p53 codon 72 polymorphisms may become a useful marker to predict the endometriosis development. In contrast, the p53 codon 11 and 248 are not candidates for the useful marker of the endometriosis screening. Although the real role of p53 polymorphism has not been clarified, it deserves more attentions in the study of endometriosis and the development of gene therapy. However, the real roles of these p53 gene polymorphisms upon endometriosis remain to be clarified. Lager cohort recruitment is request for its further clarification. After the elucidation of these issues, some tumor suppressor gene polymorphisms might become useful markers to predict the future development of endometriosis as well as the development and intervention of genetic therapy.
###end p 27
###begin article-title 28
Heritability and molecular genetic studies of endometriosis
###end article-title 28
###begin article-title 29
Demonstration of focal p53 expression without genetic alterations in endometriotic lesions
###end article-title 29
###begin article-title 30
Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci
###end article-title 30
###begin article-title 31
###xml 49 54 <span type="species:ncbi:9606">human</span>
Role of a p53 polymorphism in the development of human papilloma virus-associated cancer
###end article-title 31
###begin article-title 32
p53 polymorphism and risk of cervical cancer
###end article-title 32
###begin article-title 33
A p53 genetic polymorphism as a modulator of hepatocellular carcinoma in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers
###end article-title 33
###begin article-title 34
P53 codon 72 arg polymorphism is not a risk factor for carcinogenesis in the Chinese
###end article-title 34
###begin article-title 35
Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis
###end article-title 35
###begin article-title 36
Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study
###end article-title 36
###begin article-title 37
Analysis of p53 and ras gene mutations in endometriosis
###end article-title 37
###begin article-title 38
###xml 44 49 <span type="species:ncbi:9606">human</span>
c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis
###end article-title 38
###begin article-title 39
###xml 98 103 <span type="species:ncbi:9606">woman</span>
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53
###end article-title 39
###begin article-title 40
Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
###end article-title 40
###begin article-title 41
Current concepts in endometriosis
###end article-title 41
###begin article-title 42
###xml 97 102 <span type="species:ncbi:9606">women</span>
Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women
###end article-title 42
###begin article-title 43
Genetic influences on endometriosis in an Australian twin sample
###end article-title 43
###begin article-title 44
Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage
###end article-title 44
###begin article-title 45
Increased heterogeneity of chromosome 17 aneuploidy in endometriosis
###end article-title 45
###begin article-title 46
###xml 18 28 <span type="species:ncbi:111938">gatekeeper</span>
p53, the cellular gatekeeper for growth and division
###end article-title 46
###begin article-title 47
Clinical implications of the p53 tumor-suppressor gene
###end article-title 47
###begin article-title 48
Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53
###end article-title 48
###begin article-title 49
Codon 72 polymorphism of p53 and its association with cervical cancer
###end article-title 49
###begin article-title 50
p53 expression in ovarian borderline tumors and stage I carcinomas
###end article-title 50
###begin article-title 51
Accumulation of nuclear p53 and tumor progression in bladder cancer
###end article-title 51
###begin article-title 52
Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde
###end article-title 52
###begin article-title 53
Impact of circulating p53 autoantibody monitoring after endoscopic resection in mucosal gastric cancer
###end article-title 53
###begin article-title 54
Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy
###end article-title 54
###begin article-title 55
Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma
###end article-title 55
###begin article-title 56
Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival
###end article-title 56
###begin article-title 57
###xml 58 62 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination
###end article-title 57
###begin article-title 58
Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population
###end article-title 58
###begin article-title 59
The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity
###end article-title 59
###begin article-title 60
Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy
###end article-title 60
###begin article-title 61
P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population
###end article-title 61
###begin article-title 62
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma
###end article-title 62
###begin article-title 63
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis
###end article-title 63
###begin article-title 64
Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes
###end article-title 64
###begin article-title 65
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
###end article-title 65
###begin article-title 66
###xml 29 34 <span type="species:ncbi:9606">human</span>
Mutations of the p53 gene in human functional adrenal neoplasms
###end article-title 66
###begin article-title 67
A study of p53 gene mutations in squamous cell carcinoma in eyes
###end article-title 67
###begin article-title 68
###xml 121 126 <span type="species:ncbi:9606">human</span>
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung
###end article-title 68
###begin article-title 69
Clonal heterogeneity of p53 mutations in ovarian cancer
###end article-title 69
###begin article-title 70
Mutations of p53 gene in gastric carcinoma in Taiwan
###end article-title 70
###begin article-title 71
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease
###end article-title 71
###begin article-title 72
Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
###end article-title 72
###begin article-title 73
Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan
###end article-title 73
###begin article-title 74
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review
###end article-title 74
###begin article-title 75
###xml 33 53 <span type="species:ncbi:10566">human papillomavirus</span>
Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India
###end article-title 75
###begin article-title 76
Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk
###end article-title 76
###begin article-title 77
P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency
###end article-title 77
###begin title 78
Figures and Tables
###end title 78
###begin p 79
###xml 46 49 46 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 170 174 170 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 265 268 265 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
Electrophoresis of p53 codon 11, 72, and 248. (A) p53 codon 11 (Marker 1. Glu homozygote; 2. Gln/Lys heterozygote) (*products of non-complete PCR reaction with primers). (B) p53 codon 72 (Marker 1. Arg/Pro heterozygosity; 2. Arg homozygosity; 3. Pro homozygosity). (C) p53 codon 248 (marker 1. Trp/Gln heterozygosity; 2. Arg homozygosity)
###end p 79
###begin p 80
The primer sequences and PCR conditions for p53 codon 11, 72 and 248 gene polymorphisms
###end p 80
###begin p 81
*F and R indicate forward and reverse primers
###end p 81
###begin p 82
Genotype and allele frequency of p53 codon 11 polymorphisms in populations with and without endometriosis.
###end p 82
###begin p 83
Genotype and allele frequency of p53 codon 72 polymorphisms in populations with and without endometriosis.
###end p 83
###begin p 84
NS: non-significantly different
###end p 84
###begin p 85
Genotype and allele frequency of p53 codon 248 polymorphisms in populations with and without endometriosis.
###end p 85
###begin p 86
NS: non-significantly different
###end p 86
###begin p 87
Correlations of p53 codon 11, 72, and 248 gene polymorphisms with individual diseases
###end p 87
###begin p 88
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
a: Gene extracted from peripheral blood; b: Gene extracted from tumor tissue specimen.
###end p 88

